This study suggests that DMDD inhibits the growth of breast cancer through the phosphatidylinositol‐3‐kinase (PI3K)/serine–threonine kinase (Akt)/mammalian target of rapamycin (mTOR) signaling pathway in vitro and in vivo. This evidence concerns the gene AKT1 and breast carcinoma.